Physician

Esther Lee Kim, MD

According to 2025 Medicare claims, Esther Kim, MD (NPI: 1649539404) practices ophthalmology in the Anaheim-Santa Ana-Irvine, CA market, with the plurality of this provider's patient population coming from Orange, CA. This provider's primary affiliated billing organization is ORANGE COUNTY RETINA MEDICAL GROUP (NPI: 1750398863; TIN: 33-0688181) and primary practice location at 92705-6504.

Kim's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 998 traditional Medicare patients, billed 69,395 HCPCS/CPT codes, and received $4,888,249 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 1,188 prescription claims across 316 beneficiaries totaling $202,177 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 190 records totaling $138,963. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $5,187 to $4,888,249. Similarly, Part D prescription costs have risen steadily, from $9,240 to $202,177. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.4M$4.9M2016 Medicare payment: $5,187 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $17,410 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $96,427 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $950,587 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,490,543 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,944,161 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,149,309 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,239,152 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,888,249 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
20166088$5,187
2017112185$17,410
2018185820$96,427
20195046,769$950,587
20204917,763$1,490,543
20216019,989$1,944,161
202278017,268$3,149,309
202393242,246$4,239,152
202499869,395$4,888,249

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$107K$213K2015 Drug cost: $9,240 (USD; Tot_Drug_Cst)2016 Drug cost: $21,897 (USD; Tot_Drug_Cst)2017 Drug cost: $21,443 (USD; Tot_Drug_Cst)2018 Drug cost: $14,565 (USD; Tot_Drug_Cst)2019 Drug cost: $26,632 (USD; Tot_Drug_Cst)2020 Drug cost: $49,135 (USD; Tot_Drug_Cst)2021 Drug cost: $89,902 (USD; Tot_Drug_Cst)2022 Drug cost: $161,396 (USD; Tot_Drug_Cst)2023 Drug cost: $213,148 (USD; Tot_Drug_Cst)2024 Drug cost: $202,177 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201532131$9,240
201681302$21,897
2017122347$21,443
201897299$14,565
201995339$26,632
2020116414$49,135
2021148616$89,902
2022231920$161,396
20233041,073$213,148
20243161,188$202,177

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more211211$176
92014Established patient complete exam of visual system8793,042$101
67028Injection of drug into eye3402,472$97
92134Imaging of retina9884,148$33
92201Extended exam of the back part of the eye with retinal drawing9853,455$20

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine372,130$40,281
XiidraLifitegrast361,560$33,740
MieboPerfluorohexyloctane/Pf25263$18,593
CyclosporineCyclosporine401,980$15,036
VevyeCyclosporine20511$14,871

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.190$138,963Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Esther Lee Kim, MD?

Tedicare shows public-source Medicare data for Esther Lee Kim, MD (NPI 1649539404), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Esther Lee Kim, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Esther Lee Kim, MD?

Esther Lee Kim, MD is linked to ORANGE COUNTY RETINA MEDICAL GROUP (billing NPI 1750398863) in the available physician profile data.

Does Esther Lee Kim, MD have Open Payments data?

Esther Lee Kim, MD has 190 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.